How does the interaction between age and genetics affect ADHD treatment response?

PostedAugust 19, 2025

UpdatedSeptember 4, 2025

ByMy Patient Advice

Author: Lucia Alvarez, MSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

Understanding the interaction between genetics, age, and treatment for ADHD is essential for creating personalised ADHD care plans. A person’s genetic profile can influence how well they respond to ADHD treatments at different life stages, from childhood to adulthood. That is why an age-specific ADHD therapy approach, aligned with genetic insights, supports more precise and adaptive care.

Age, genetics, and treatment, why timing matters

Effective treatment depends on when and how genetic factors are considered.

Genetic profile dictates drug response

Genetic variations affecting metabolism, neurochemical pathways, and receptor sensitivity can alter responses to ADHD medications. For instance, genes involved in dopamine regulation can influence stimulant effectiveness in both children and adults.

Age-specific ADHD therapy and maturation

Children’s brains are more plastic, potentially responding better to early interventions. As people age, hormonal changes, environmental stress, or shifting lifestyle demands may require adjustments to treatment plans, an outcome shaped by their genetic predisposition.

Personalised ADHD care via pharmacogenomics

Genetic testing can predict which medications are likely to work or cause side effects. Combined with age-based factors, like liver enzyme function or hormonal levels, personalised treatment plans become more precise across the lifespan.

Long-term adaptability and genetics

As individuals mature, the interaction between their genetics, age, and treatment for ADHD evolves. New challenges, like work-related stress or co-occurring conditions, may emerge and necessitate retesting and therapeutic realignment.

Recognising how age and genetics interact with treatment response encourages lifelong, dynamic ADHD care. Visit providers like ADHD Certify for assessments that integrate genetic profiles with age-adapted therapy planning.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Genetic Factors in ADHD.

Lucia Alvarez, MSc

Author

Lucia Alvarez is a clinical psychologist with a Master’s in Clinical Psychology and extensive experience providing evidence-based therapy and psychological assessment to children, adolescents, and adults. Skilled in CBT, DBT, and other therapeutic interventions, she has worked in hospital, community, and residential care settings. Her expertise includes grief counseling, anxiety management, and resilience-building, with a strong focus on creating safe, supportive environments to improve mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.